Amplitude AMPL 深 沪
等待开盘 07-08 09:30:00 美东时间
9.16
+0.250
+2.81%
华盛通- 最 高9.355
- 今 开9.09
- 成交量 269.18万股
- 最 低 8.81
- 昨 收 8.91
- 总市值 12.15亿
- 52周最高 14.49
- 市盈率 静 --
- 换手率 2.03%
- 52周最低 5.51
- 委 比 -54.81%
- 总股本 1.33亿
- 历史最高 87.98
- 量 比 0.75
- 振 幅 6.12%
- 历史最低 5.51
- 每 手 1
- 风险率 2.15%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅392.61%！Chardan Capital维持EyePoint"买入"评级，上调目标价至65美元
今日重点评级关注：Chardan Capital：维持EyePoint"买入"评级，目标价从29美元升至65美元；康托·菲茨杰拉德：维持Hyperliquid Strategies"超配"评级，目标价从8美元升至18.4美元
07-02 18:41
Raymond James Initiates Coverage On Amplitude with Strong Buy Rating, Announces Price Target of $10
Raymond James analyst Mark Cash initiates coverage on Amplitude (NASDAQ:AMPL) with a Strong Buy rating and announces Price Target of $10.
07-01 16:47
Graham, Appian And Other Big Stocks Moving Lower In Monday's Pre-Market Session
U.S. stock futures rise, Nasdaq up 1%. Graham Corp shares down 8.7%. Other stocks declining in pre-market trading: BVC, TLK, INDP, APPN, WIX, KB, SSSS, IPSC, AMPL, ICCM, SBSW, ROMA.
06-08 20:04
美股大行评级 | 绩后暴跌10%，ARM仍获高盛、富国银行等多家大行上调目标价；康宁、优步、飞塔信息、西维斯、Agilon Health等获多家大行上调目标价
今日重点评级关注：Citizens：维持BioCryst制药"跑赢大市"评级，目标价从25美元升至28美元；富国银行：维持曼恩凯德生物医疗"超配"评级，目标价从8美元升至10美元
05-08 12:05
Amplitude Inc. Leans Into AI Amid Margin Pressure
Amplitude Inc Class A (($AMPL)) has held its Q1 earnings call. Read on for the ...
05-08 10:40
12 Information Technology Stocks Moving In Wednesday's After-Market Session
Gainers Global Engine Group (NASDAQ:GLE) shares increased by 53.2% to $0.55 du...
05-07 05:03
Earnings Scheduled For May 6, 2026
Companies Reporting Before The Bell • Deluxe (NYSE:DLX) is expected to report q...
05-07 05:03
Amplitude shares are trading lower after the company reported mixed Q1 financial results and issued Q2 adjusted EPS guidance below estimates. Also, the company cut its FY26 adjusted EPS guidance below estimates.
Amplitude shares are trading lower after the company reported mixed Q1 financia...
05-07 05:03
Amplitude Lowers FY2026 Adj EPS Guidance from $0.08-$0.13 to $0.03-$0.06 vs $0.11 Est; Raises FY2026 Sales Guidance from $390.000M-$398.000M to $397.000M-$403.000M vs $395.145M Est
Amplitude (NASDAQ:AMPL) lowers FY2026 Adj EPS guidance from $0.08-$0.13 to $0.03-$0.06 vs $0.11 analyst estimate. Raises FY2026 sales outlook from $390.000 million-$398.000 million to $397.000 million-$403.000 million vs
05-07 04:56
Amplitude Q1 Adj. EPS $(0.02) Misses $(0.01) Estimate, Sales $93.492M Beat $92.951M Estimate
Amplitude (NASDAQ:AMPL) reported quarterly losses of $(0.02) per share which missed the analyst consensus estimate of $(0.01) by 100 percent. The company reported quarterly sales of $93.492 million which beat the
05-07 04:22
